Researchers from Duke University School of Medicine have developed a potential new drug, HS-291, which can destroy the Lyme disease-causing bacteria Borrelia burgdorferi. It does this by targeting and inhibiting a specific type of enzyme within the bacteria. The researchers hope their discovery will help patients suffering from persistent and widespread symptoms to find relief.

This novel and selective treatment was inspired by research that targets cancer tumors and was partially funded by Project Lyme, in partnership with the Bay Area Lyme Foundation.

Learn more: https://projectlyme.org/no...

#projectlyme #Lyme #tickbornediseases #lymediseaseawareness #chronicillness #Chronicpain #Health #tickbite #medicine #science #research